Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03564626 · ClinicalTrials.gov registry record · NA
Health IT Generated PROs to Improve Outcomes in Cirrhosis
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 232
- Enrollment target
NCT03564626 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 232 participants.
The verdict
NCT03564626, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 232 participants
- Enrollment target
Study Summary
SPECIFIC AIM 1: To evaluate in a multi-center, randomized trial the effectiveness of PROs elicited using PatientBuddy and EncephalApp on the prevention of avoidable 30 day readmissions in patients with cirrhosis and their caregivers compared to standard of care.
Interventions
- OTHER Health-IT +/- Scheduled Follow Up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2018-06-22 |
| Est. Completion | 2024-05-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03564626
The ClinicalTrials.gov registry entry for NCT03564626 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 232 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Health-IT +/- Scheduled Follow Up is the first listed.
NCT03564626 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03564626 about?
NCT03564626 is a clinical study titled "Health IT Generated PROs to Improve Outcomes in Cirrhosis". SPECIFIC AIM 1: To evaluate in a multi-center, randomized trial the effectiveness of PROs elicited using PatientBuddy and EncephalApp on the prevention of avoidable 30 day readmissions in patients with cirrhosis and their caregivers compared to standard of care.
What is the current status of trial NCT03564626?
This trial is currently completed. It is a NA study. The enrollment target is 232 participants. The study started on 2018-06-22. Estimated completion is 2024-05-22.
What interventions are being tested in trial NCT03564626?
The interventions under investigation include: Health-IT +/- Scheduled Follow Up (OTHER).
Who is sponsoring clinical trial NCT03564626?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.